Sign in

    Anna Barsanti

    Research Analyst at Wolfe Research, LLC

    Anna Barsanti is an Equity Research Associate at Wolfe Research, LLC, specializing in equity research with a notable background in healthcare and research analysis. She supports coverage across select healthcare companies, leveraging strong analytical skills to contribute to investment insights and thematic research, though verified performance metrics and rankings have not been publicly reported. Barsanti began her career in research roles and transitioned into equity research, currently working out of New York City for Wolfe Research. Her professional credentials and securities licenses are not disclosed in public records, and she has yet to attain widely recognized analyst achievements or third-party rankings.

    Anna Barsanti's questions to HCA Healthcare (HCA) leadership

    Anna Barsanti's questions to HCA Healthcare (HCA) leadership • Q4 2024

    Question

    Anna Barsanti, on for Justin Lake, asked about the potential impact of site-neutral payments, whether it alters HCA's outpatient ASC strategy, and for the same-store ASC revenue growth in the quarter.

    Answer

    CFO Mike Marks stated that HCA opposes site-neutral cuts and has not seen a bill with enough detail to size the impact, though he noted the impact would vary depending on the scope of procedures included. He reported ASC revenue growth was 5% to 6%. CEO Sam Hazen added that site-neutral policy would not cause HCA to rethink its outpatient network strategy.

    Ask Fintool Equity Research AI